← Back to Search

Intensification of insulin regimen/Nutrition for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 2 Diabetics with HbA1c > 7.5% with short duration of diabetes <5 years or Type 2 Diabetics with HbA1c > 7.5% longer duration of diabetes >5 years
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 week
Awards & highlights

Study Summary

This trial will test if there are differences in how the brain processes sugar in people with type 2 diabetes, depending on how long they have had the disease. Reversing these changes may improve diabetes control.

Eligible Conditions
  • Type 2 Diabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intracerebral concentrations of glucose
Intracerebral concentrations of glucose between T2DM patients
Secondary outcome measures
Delayed Matching to Sample (DMS)
Multitasking Test (MTT)
Paired Associates Learning (PAL)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Diabetic with short durationExperimental Treatment1 Intervention
Type 2 diabetics with HbA1c > 7.5 % with short duration of diabetes < 5 years
Group II: Diabetic with long durationExperimental Treatment1 Intervention
Type 2 diabetics with HbA1c > 7.5 % with short duration of diabetes > 5 years

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,737,668 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,730 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings remaining for this research endeavor?

"According to the clinicaltrials.gov database, this research is presently enrolling patients and was initially posted on October 12th 2021 with a subsequent update made on December 6th 2021."

Answered by AI

What is the aggregate number of participants in this experiment?

"Affirmative. Clinicaltrials.gov states that this investigation, which was announced on October 12th 2021, is actively looking for participants to take part in the trials. In total, 30 patients will be accepted across a single site."

Answered by AI

Are there any qualification criteria that would allow me to join this experiment?

"This medical study is currently enrolling 30 individuals with type 2 diabetes who are between 18 and 60 years old. To qualify, people must show an HbA1c value of above 7.5% and have had the condition for either less than 5 or more than 5 years respectively."

Answered by AI

What is the paramount objective of this research?

"In this trial, the main goal is to ascertain intracerebral concentrations of glucose over 12 weeks. Secondary objectives include Reaction Time (RTI), Pattern Recognition Memory (PRM) and Multitasking Test (MTT). Each task requires a different length of administration time: 3 minutes for RTI; 4 minutes for PRM; 8 minutes for MTT. Outcome measures are based on response latencies, error scores and percentage/number of correct trials."

Answered by AI

Is there an age restriction for participants of this research?

"This study is open to those who are of age and not exceeding 60 years old."

Answered by AI

Who else is applying?

What state do they live in?
Connecticut
What site did they apply to?
Yale New Haven Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

Interested in new medical potential for managing diabetes.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
2021. "Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04283617.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top